IBDEI26W ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36765,1,4,0)
 ;;=4^C82.40
 ;;^UTILITY(U,$J,358.3,36765,2)
 ;;=^5001501
 ;;^UTILITY(U,$J,358.3,36766,0)
 ;;=C82.19^^169^1859^28
 ;;^UTILITY(U,$J,358.3,36766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36766,1,3,0)
 ;;=3^Follicular lymphoma grade II, extrnod and solid organ sites
 ;;^UTILITY(U,$J,358.3,36766,1,4,0)
 ;;=4^C82.19
 ;;^UTILITY(U,$J,358.3,36766,2)
 ;;=^5001480
 ;;^UTILITY(U,$J,358.3,36767,0)
 ;;=C82.39^^169^1859^31
 ;;^UTILITY(U,$J,358.3,36767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36767,1,3,0)
 ;;=3^Follicular lymphoma grade IIIa, extrnod and solid organ sites
 ;;^UTILITY(U,$J,358.3,36767,1,4,0)
 ;;=4^C82.39
 ;;^UTILITY(U,$J,358.3,36767,2)
 ;;=^5001500
 ;;^UTILITY(U,$J,358.3,36768,0)
 ;;=C82.30^^169^1859^32
 ;;^UTILITY(U,$J,358.3,36768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36768,1,3,0)
 ;;=3^Follicular lymphoma grade IIIa, unspecified site
 ;;^UTILITY(U,$J,358.3,36768,1,4,0)
 ;;=4^C82.30
 ;;^UTILITY(U,$J,358.3,36768,2)
 ;;=^5001491
 ;;^UTILITY(U,$J,358.3,36769,0)
 ;;=C82.29^^169^1859^25
 ;;^UTILITY(U,$J,358.3,36769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36769,1,3,0)
 ;;=3^Follicular lymph grade III, unsp, extrnod and solid org sites
 ;;^UTILITY(U,$J,358.3,36769,1,4,0)
 ;;=4^C82.29
 ;;^UTILITY(U,$J,358.3,36769,2)
 ;;=^5001490
 ;;^UTILITY(U,$J,358.3,36770,0)
 ;;=C82.20^^169^1859^30
 ;;^UTILITY(U,$J,358.3,36770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36770,1,3,0)
 ;;=3^Follicular lymphoma grade III, unspecified, unspecified site
 ;;^UTILITY(U,$J,358.3,36770,1,4,0)
 ;;=4^C82.20
 ;;^UTILITY(U,$J,358.3,36770,2)
 ;;=^5001481
 ;;^UTILITY(U,$J,358.3,36771,0)
 ;;=C82.09^^169^1859^26
 ;;^UTILITY(U,$J,358.3,36771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36771,1,3,0)
 ;;=3^Follicular lymphoma grade I, extrnod and solid organ sites
 ;;^UTILITY(U,$J,358.3,36771,1,4,0)
 ;;=4^C82.09
 ;;^UTILITY(U,$J,358.3,36771,2)
 ;;=^5001470
 ;;^UTILITY(U,$J,358.3,36772,0)
 ;;=C82.10^^169^1859^29
 ;;^UTILITY(U,$J,358.3,36772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36772,1,3,0)
 ;;=3^Follicular lymphoma grade II, unspecified site
 ;;^UTILITY(U,$J,358.3,36772,1,4,0)
 ;;=4^C82.10
 ;;^UTILITY(U,$J,358.3,36772,2)
 ;;=^5001471
 ;;^UTILITY(U,$J,358.3,36773,0)
 ;;=C82.00^^169^1859^27
 ;;^UTILITY(U,$J,358.3,36773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36773,1,3,0)
 ;;=3^Follicular lymphoma grade I, unspecified site
 ;;^UTILITY(U,$J,358.3,36773,1,4,0)
 ;;=4^C82.00
 ;;^UTILITY(U,$J,358.3,36773,2)
 ;;=^5001461
 ;;^UTILITY(U,$J,358.3,36774,0)
 ;;=C82.90^^169^1859^36
 ;;^UTILITY(U,$J,358.3,36774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36774,1,3,0)
 ;;=3^Follicular lymphoma, unspecified, unspecified site
 ;;^UTILITY(U,$J,358.3,36774,1,4,0)
 ;;=4^C82.90
 ;;^UTILITY(U,$J,358.3,36774,2)
 ;;=^5001541
 ;;^UTILITY(U,$J,358.3,36775,0)
 ;;=C82.99^^169^1859^35
 ;;^UTILITY(U,$J,358.3,36775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36775,1,3,0)
 ;;=3^Follicular lymphoma, unsp, extranodal and solid organ sites
 ;;^UTILITY(U,$J,358.3,36775,1,4,0)
 ;;=4^C82.99
 ;;^UTILITY(U,$J,358.3,36775,2)
 ;;=^5001550
 ;;^UTILITY(U,$J,358.3,36776,0)
 ;;=C84.00^^169^1859^60
 ;;^UTILITY(U,$J,358.3,36776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36776,1,3,0)
 ;;=3^Mycosis fungoides, unspecified site
 ;;^UTILITY(U,$J,358.3,36776,1,4,0)
 ;;=4^C84.00
 ;;^UTILITY(U,$J,358.3,36776,2)
 ;;=^5001621
 ;;^UTILITY(U,$J,358.3,36777,0)
 ;;=C84.09^^169^1859^59
 ;;^UTILITY(U,$J,358.3,36777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36777,1,3,0)
 ;;=3^Mycosis fungoides, extranodal and solid organ sites
